A carregar...
Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
The risk of hepatocellular carcinoma recurrence is universal regardless of the treatment modality applied, and secondary prevention is still an unmet issue even though the elimination of hepatitis C (HCV) with direct antiviral agents (DAAs) was expected to be one of the new options. Unfortunately, t...
Na minha lista:
| Publicado no: | Viruses |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563506/ https://ncbi.nlm.nih.gov/pubmed/31052463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v11050406 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|